You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
July 2010
Br J Cardiol 2010;17:161-2
The prevalence of atrial fibrillation (AF) in the UK alone is estimated to be 1% of the population (approximately 610,000) and rises with age from
July 2010
Br J Cardiol 2010;17:168-170
A novel, catheter-based technique is looking promising for the treatment of refractory hypertension. Renal sympathetic hyperactivity is associated with the development of
July 2010
Br J Cardiol 2010;17:163-5
A study of a new drug for atrial fibrillation, apixaban (Pfizer/Bristol-Myers Squibb), has been stopped early because of
May 2010
Br J Cardiol 2010;17:111-5
March 2010
Br J Cardiol 2010;17:55-6
March 2010
Br J Cardiol 2010;17:86–8
March 2010
Br J Cardiol 2010;17:89–92
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
You need to be a member to download PDF's.
Sign up for free membership, or log in.
Find out more about our membership benefits